Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes

Diabetologia

Volumn 43, Issue 2, 2000, Pages 148-155

  Lehto, S ^a   Ronnemaa T ^b   Pyorala K ^a   Laakso, M ^a,c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Central obesity; Death from CHD; Hypertension; Insulin; Insulin resistance syndrome; Lipids; Sex; Smoking; Type II diabetes; Urinary protein

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INSULIN;

ARTICLE; BODY MASS; CAUSE OF DEATH; CIGARETTE SMOKING; DISEASE ASSOCIATION; FOLLOW UP; HYPERINSULINEMIA; HYPERTENSION; HYPOTHESIS; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MORTALITY; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RISK FACTOR;

EID: 0034002064     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050023     Document Type: Article

References (58)

1. 1. Laakso M, Lehto S (1997) Epidemiology of macrovascular disease in diabetes. Diabetes Rev 5: 294-315
2. 2. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038
3. 3. Stamler J, Vaccaro O, Neaton J, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444
4. 4. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 399: 229-234
5. 5. Laakso M, Lehto S, Penttilä I, Pyörälä K (1993) Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88: 1421-1430
6. 6. Goldberg RB (1981) Lipid disorders in diabetes. Diabetes Care 4: 561-572
7. 7. Howard BV, Savage BJ, Bennion LJ, Bennett PH (1978) Lipoprotein composition in diabetes mellitus. Atherosclerosis 30: 153-162
8. 8. Laakso M, Barrett-Connor E (1989) Asymptomatic hyperglycaemia is associated with lipid and lipoprotein changes favouring atherosclerosis. Arteriosclerosis 9: 665-672
9. 9. Laakso M, Voutilainen E, Sarlund H, Aro A, Pyörälä K, Penttilä I (1985) Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics. Atherosclerosis 56: 271-281
10. 10. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M (1994) NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43: 960-967
11. 11. Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V (1997) Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 46: 1354-1359
12. 12. Turner RC, Millns H, Neil HAW et al. (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23). BMJ 316: 823-828
13. 13. Ruige JB, Assenfelt WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM (1998) Insulin and risk of cardiovascular disease. A meta-analysis. Circulation 97: 996-1001
14. 14. Laakso M (1996) Insulin resistance and coronary heart disease. Curr Opin Lipidol 7: 217-226
15. 15. Pyörälä M, Miettinen H, Laakso M, Pyörälä K (1998) Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men. The 22-year follow-up results of the Helsinki Policemen Study. Circulation 98: 398-404
16. 16. Jarrett RJ (1994) Why is insulin not a risk factor for coronary heart disease? Diabetologia 37: 945-947
17. 17. Wingard DL, Barrett-Connor EL, Ferrara A (1995) Is insulin really a heart disease risk factor? Diabetes Care 18: 1299-1304
18. 18. Santen RJ, Willis PW, Fajans SS (1972) Atherosclerosis in diabetes mellitus. Correlation between serum lipid levels, adiposity and serum insulin level. Arch Intern Med 130: 833-843
19. 19. Hillson RM, Hockaday TD, Mann JI, Newton DJ (1984) Hyperinsulinaemia is associated with development of electrocardiographic abnormalities in diabetics. Diabetes Res 1: 143-149
20. 20. Standl E, Janka HU (1985) High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes. Horm Metab Res 15 [Suppl]: S46-S51
21. 21. Rönnemaa T, Laakso M, Pyörälä K, Kallio V, Puukka P (1991) High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb 11: 80-90
22. 22. Fontbonne A, Eschwege E (1987) Diabetes, hyperglycaemia, hyperinsulinaemia and atherosclerosis: epidemiological data. Diabetes Metab 13: 350-353
23. 23. Hanefeld M, Schmechel H, Schwanebeck U, Lindner J, the DIS Group (1997) Predictors of coronary heart disease and death in NIDDM: The Diabetes Intervention Study experience. Diabetologia 40 [Suppl 2]S123-S124
24. 24. Jarrett RJ, McCartney P, Keen H (1982) The Bedford Study: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22: 79-84
25. 25. Stout RW (1990) Insulin and atheroma: 20-year perspective. Diabetes Care 13: 631-654
26. 26. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I (1988) Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 11: 449-463
27. 27. Madsbad S, Alberti KG, Binder C et al. (1979) Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. BMJ 2: 1257-1259
28. 28. World Health Organization (1985) Diabetes mellitus. Report of WHO Study Group. WHO Technical Report Series No 727, World Health Organization, Geneva
29. 29. World Health Organization (1983) Proposal for the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease and Protocol (MONICA Project). World Health Organization, WHO/MNC/82.1 Rev. 1, Geneva
30. 30. Faber OK, Binder C (1977) C-peptide response to glucagon: a test for the residual B-cell function in diabetes mellitus. Diabetes 26: 605-610
31. 31. Kostner G (1976) Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 22: 695-698
32. 32. Kleinbaum DG, Kupper LL, Muller KE (1988) Applied Regression Analysis and Other Multivariable Methods. Kent Publishing, Boston
33. 33. Stevens J (1986) Applied Multivariate Statistics for the Social Sciences. Lawrence Erlbaum Associates, Hillsdale, pp 337-350
34. 34. Cox DR (1972) Regression models and life-tables. J R Stat Soc 34: 187-201
35. 35. Laakso M, Rönnemaa T, Lehto S, Puukka P, Kallio V, Pyörälä K (1995) Does NIDDM increase the risk for coronary heart disease similarly in both low-and high-risk populations? Diabetologia 38: 487-493
36. 36. Peters N, Hales CN (1965) Plasma insulin concentrations after myocardial infarction. Lancet i: 1144-1145
37. 37. Nikkilä EA, Miettinen TA, Vesenne MR, Pelkonen R (1965) Plasma insulin in coronary heart disease: response to oral and intravenous glucose and tolbutamide. Lancet ii: 508-511
38. 38. Laakso M (1993) How good a marker is insulin level for insulin resistance? Am J Epidemiol 137: 959-965
39. 39. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M (1995) Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation 91: 831-837
40. 40. Lempiäinen P, Mykkänen L, Pyörälä K, Laakso M, Kuusisto J (1999) Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100: 123-128
41. 41. Despres JP, Lamarche B, Mauriege P et al. (1996) Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334: 952-957
42. 42. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368
43. 43. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL (1983) Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118: 326-337
44. 44. Laakso M, Pyörälä K, Voutilainen E, Marniemi J (1987) Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects. Am J Epidemiol 125: 611-621
45. 45. Byrne CD, Wareham NJ, Day NE, McLeish R, Williams DRR, Hales CN (1995) Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance. Diabetologia 38: 1358-1366
46. 46. Williams PT, Haskell WL, Vranizan KM, Krauss RM (1995) The associations of high-density lipoprotein subclasses with insulin and glucose levels, physical activity, resting heart rate, and regional adiposity in men with coronary artery disease: the Stanford Coronary Risk Intervention Project Baseline Survey. Metabolism 44: 106-114
47. 47. Laakso M, Sarlund H, Mykkänen L (1990) Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10: 223-231
48. 48. Ferrannini E, Muscelli P, Stern MP, Haffner SM (1996) Differential impact of insulin and obesity on cardiovascular risk factors in non-diabetic subjects. Int J Obes 20: 7-14
49. 49. Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J (1995) Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44: 1121-1125
50. 50. Burchfiel CM, Curb JD, Sharp DS, Rodriques BL, Arakaki R, Chyo PH, Yano K (1995) Distribution and correlates of insulin in elderly men. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol 15: 2213-2221
51. 51. Ferrannini E, Buzzigoli G, Bonadonna R et al. (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350-357
52. 53. Edwards KL, Austin MA, Newman B, Mayer E, Krauss R, Selby J (1994) Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb 14: 1940-1945
53. 54. Meigs JB, D'Agostino RB, Wilson PW, Cupples LA, Nathan DM, Singer DE (1997) Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46: 1594-1600
54. 55. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D (1987) Disproportionate elevation of immunoreactive proinsulin in Type II (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30: 698-702
55. 56. Saad MF, Kahn SE, Nelson RG et al. (1990) Disproportionately elevated proinsulin in Pima Indians with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 70: 1247-1253
56. 57. Davis SN, Piatti PM, Monti L et al. (1993) Proinsulin and insulin concentrations following intravenous glucose challenge in normal, obese, and non-insulin-dependent diabetic subjects. Metabolism 42: 30-35
57. 58. Haffner SM, Mykkänen L, Valdez RA, Stern MP (1990) Evaluation of two insulin assays in insulin resistance syndrome (Syndrome X). Arterioscler Thromb 14: 1430-1437
58. 59. Nagi DK, Hendra TJ, Ryle AJ et al. (1990) The relationships of concentration of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in Type II (non-insulin-dependent) diabetic subjects. Diabetologia 33: 532-537